Thu Nov 20 21:50:00 UTC 2025: Here’s a news article summarizing the provided text, written as if by Michael Bromberg, a finance editor with a decade of experience:

Market Tumbles Despite Strong Earnings Reports; Walmart Soars

By Michael Bromberg

Wall Street experienced a perplexing session Thursday, with major indices closing in the red despite some stellar earnings reports. The tech sector took the brunt of the losses, pulling the Dow Jones Industrial Average down 0.8%, the S&P 500 1.6%, and the Nasdaq a hefty 2.2%.

Nvidia (NVDA), despite exceeding expectations with its quarterly results, saw its shares slide 3.2%. This pullback reverberated throughout the AI chipmaker sector, dragging down Advanced Micro Devices (AMD) by nearly 8% and Broadcom (AVGO) by 2%. The PHLX Semiconductor Index suffered a nearly 5% decline, and Nvidia memory chip partner Micron Technology (MU) plummeted 10.9%.

Jacobs Solutions (J) was the worst performer in the S&P 500, with shares falling around 11% following a year-over-year decline in quarterly profits. The company attributed the results to changes in the value of its investment in Amentum (AMTM).

Cryptocurrencies also faced headwinds, with Bitcoin (BTCUSD) continuing its downtrend. Robinhood Markets (HOOD), which facilitates crypto trading, dropped about 10%, while Coinbase Global (COIN) fell 7.4%.

Amidst the gloom, Walmart (WMT) shone brightly. Shares of the retail giant jumped nearly 7%, topping the S&P 500. Strong e-commerce sales and advertising revenue fueled the positive performance, potentially signaling healthy U.S. consumer spending as the holiday season approaches.

In other news, Regeneron Pharmaceuticals (REGN) received FDA approval for its Eylea HD eye treatment for macular edema and a monthly dosing option for several other eye conditions, sending its shares up 5%. Solventum (SOLV) shares gained nearly 3% after announcing its acquisition of Acera Surgical, a bioscience firm, for $725 million plus potential future payments.

Thursday’s market action underscored the ongoing volatility and complex interplay of factors influencing investor sentiment. While individual companies may post impressive results, broader economic anxieties appear to be weighing on market performance.

Read More